As above-mentioned, TMAO increases intracellular ROS, and ROS activates NF-B signaling by triggering the IKK complex, leading to IB phosphorylation and degradation
In theory, this suggests GLP-1 drugs could help calm inflammatory skin diseases, including eczema, by: Reducing systemic inflammation Improving insulin resistance (which is linked to some eczema subtypes) Supporting a healthier gut-skin axis (via weight loss and metabolic balance) However, the clinical evidence is not yet conclusive
Inflammation also raises an individuals risk of developing chronic diseases, like HIV
Avoid Overexposure Never leave your medication in a parked car
An informed choice between Liraglutide and Semaglutide hinges on individual patient needs preferences, and a thorough discussion with qualified healthcare professionals